# Monopar Therapeutics: Form 8-K, filed Nov 16, 2022

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2022-11-16
- Accepted by EDGAR: Nov 16, 2022, 07:20 ET
- Period: 2022-11-16
- Accession: 0001654954-22-015397
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000165495422015397/mnpr_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000165495422015397/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000165495422015397/mnpr_8k.htm

Filed Nov 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001654954-22-015397. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.
